Aferna Bio
PrivateLast Round
VC Round
Jun 4, 2025
Company Overview
Aferna Bio operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a VC Round in June 2025.
Aferna Bio is an agtech company that develops ribonucleic acid-based molecular tools to create beneficial crop traits by working in partnership with nature.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aferna Bio Comparables
Compare Aferna Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terrana Biosciences | 88% | |
| Decibel Bio | 84% | |
| Epicrop Technologies | 81% |
For institutional investors. Book with your work email.
Aferna Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 4, 2025 | ||||
| Seed | Jan 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aferna Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioGenerator Ventures | Seed |
| Plaisance Capital Management | Seed |
| Leaps by Bayer | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2025
$4M round with participation from Leaps by Bayer.
- Jan 1, 2022
Seed round raised with participation from Leaps by Bayer and BioGenerator Ventures.
For institutional investors. Book with your work email.
Aferna Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aferna Bio's valuation, stock price, and market status.
Is Aferna Bio a public or private company?
Aferna Bio is a private company.
What is the current stock price of Aferna Bio?
Aferna Bio is a private company, so its shares have no public market price. Caplight tracks Aferna Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aferna Bio worth (valuation)?
Valuation information for Aferna Bio is not publicly available.
Can I buy Aferna Bio stock?
Aferna Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aferna Bio's last funding round?
Aferna Bio's most recent funding round was VC Round on June 4, 2025.
Who are the main investors in Aferna Bio?
Key investors in Aferna Bio include BioGenerator Ventures, Plaisance Capital Management, Leaps by Bayer.
Will Aferna Bio IPO soon?
No public IPO plans have been announced for Aferna Bio.
How can I track Aferna Bio secondary market activity?
Caplight tracks bids, offers, and trades in Aferna Bio's shares on secondary markets.